The funding comes from several industry executives and will be used by TerViva to commercialize its Pongamia-derived oil and new protein product. In addition to the $54 million, TerViva expects...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)